NAUT
NAUT
NASDAQ · Life Sciences Tools & Services

Nautilus Biotechnology Inc

$0.89
+0.00 (+0.22%)
As of Aug 16, 10:35 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,877.6% upside
Low Target $24.26
Average Target $26.56
High Target $41.87
Current Price $0.89
Current
$0.89
Target
$26.56
$24.26 $26.56 avg $41.87
Scenario Analysis
Bear Case
$24.26
2,619.7%
Low target
Base Case
$26.56
+2,877.6%
Avg target
Bull Case
$41.87
+4,593.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.31
-79.3% from high
52-Week Low
$0.62
+43.9% from low
Target vs 52W High
$26.56
+516.2% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -37.3%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -20.8%
A
Agilent Technologies Inc
Strong Buy 29 76% $64.69 -56.4%
WAT
Waters Corp
Hold 31 55% $189.60 -52.7%
IQV
Iqvia Holdings Inc
Strong Buy 28 79% $82.96 -65.4%
ILMN
Illumina Inc
Buy 28 61% $169.36 -10.1%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -87.8%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -60.7%